4587-PEPTIDREAM研究会(中・長期ホルダー専用)短期・売り煽り禁止!!の掲示板
-
5408
>>4913
肩書は相変わらずですね。
皆さま、よいお年をお迎えください。
Keynote
Recent Progress in the Discovery and Development of Macrocyclic Peptides
PeptiDream will present some of its recent progress in the discovery and development of therapeutics arising from its PDPS technology. PDPS technology has proven to be a powerful hit finding platform effective against almost any target. PeptiDream has evolved to turn those initial constrained peptide hit candidates into peptide therapeutics, small molecule therapeutics, and peptide-drug conjugates.
Keynote Presentations
Tuesday, 27 February 2018 2:30pm - 3:00pm
Keynote Speaker
Patrick Reid, PhD
Chief Scientific Officer
PeptiDream, Inc.
ttps://lifesciences.knect365.com/asia-tides/agenda/1#recent-progress-in-the-discovery-and-development-of-macrocyclic-peptides -
5575
>>4913
リックさんの肩書が修正されましたね。
AsiaTIDES 2018
February 27-March 1, 2018
Westin Miyako Kyoto,
Kyoto, Japan
PATRICK REID, PHD
CEO at PeptiDream, Inc.
AGENDA SESSIONS
Recent Progress in the Discovery and Development of Macrocyclic Peptides
Feb 27, 2:30pm
ttps://lifesciences.knect365.com/asia-tides/speakers/patrick-reid-phd
犬猫 2017年10月15日 16:27
リックさんの肩書は直してもらったらどうでしょうか。
AsiaTIDES: Oligonucleotide & Peptide Therapeutics
February 27-March 1, 2018
Westin Miyako Kyoto,
Kyoto, Japan
Global Experts Help Accelerate Your Molecules to Market
Ekkehard Leberer, Ph.D.
Senior Director, R&D Alliance Management
Sanofi
Junichi Koga, Ph.D.
Head of R&D Division, Executive Officer
Daiichi Sankyo
Patrick Reid, Ph.D.
Chief Scientific Officer
PeptiDream, Inc.
ttps://lifesciences.knect365.com/asia-tides/